In the first part of this year’s edition of Generics Bulletin’s annual ranking of the world’s top 50 generics and biosimilars firms, we listed the top ten off-patent companies to see how recent developments had shaken up the table in 2019. (Also see "A Year Of Surprises Shakes Up Industry Top 10" - Generics Bulletin, 19 August, 2020.)
However, major movements were not limited to the industry’s largest 10 players, as demonstrated by the second part of our